![]() | Only 14 pages are availabe for public view |
Abstract The present study was conducted to: 1. Investigate angiogenesis in oral epithelial dysplasia and oral squamous cell carcinoma using CD105. 2. Correlate this CD105 expression with degree of dysplasia and grade of carcinoma. 3. Investigate angiogenesis in oral epithelial dysplasia and oral squamous cell carcinoma using CD31 4. Correlate this CD31 expression with degree of dysplasia and grade of carcinoma. 5. Compare the CD105 expression with CD31 expression in order to evaluate whether CD105 is more accurate in identifying the tumorinduced angiogenesis than commonly used panendothelial marker CD31, which considered an excellent marker for the normal vasculature. |